Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

COMPARISON 1. ARIPIPRAZOLE vs QUETIAPINE

Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia

It is very uncertain whether COMPARISON 2. ARIPIPRAZOLE changes adverse effects: extrapyramidal symptoms compared with QUETIAPINE (very low certainty).

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
RR 2.8 [0.64, 12.31]
4 studies · 348 participants
Very low

COMPARISON 1. ARIPIPRAZOLE vs RISPERIDONE

Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia

COMPARISON 3. ARIPIPRAZOLE may leads to lower adverse effects: extrapyramidal symptoms compared with RISPERIDONE (low certainty).

1 finding from 1 review

Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only
RR 0.39 [0.31, 0.5]
31 studies · 2605 participants
Low